
Viking Therapeutics
Viking Therapeutics soared 10.6% following Pfizer’s announcement that it would halt development of its daily weight-loss drug, danuglipron, after a trial participant experienced potential liver
Manage your own investments using market-leading trading apps.
When you invest with Cratos Asset Management, you get access to our supporting services.
Let us manage your investment portfolio from start to finish.
We create and manage a long-term portfolio of world-class companies to meet your goals and appetite for risk.
Cratos Asset Management offers tax-efficient structures through Glacier's Global Investment Plan to ensure you maximise your tax benefits.
The Cratos Worldwide Flexible Fund.
Access to a host of third party unit trusts
Viking Therapeutics soared 10.6% following Pfizer’s announcement that it would halt development of its daily weight-loss drug, danuglipron, after a trial participant experienced potential liver
Palantir Technologies jumped 4.6% after NATO confirmed it finalized a deal to acquire Palantir’s AI-powered Maven Smart System. The technology will be deployed within NATO’s
Danaher the life sciences company rose 0.8% after Barclays upgraded the stock to overweight from equal weight, citing its diagnostics strength and bioprocessing momentum despite
Lockheed Martin the defense stock rose 2.9% as defense names broadly advanced after President Trump pledged to seek a $1 trillion defense budget for the
Tesla the EV maker delivered 336,681 vehicles in Q1 2025, falling short of Wall Street’s 380,000 estimate. This marked Tesla’s weakest quarter since Q2 2022.
Meta Platforms, the Facebook parent, dipped after a US Senate investigative subcommittee launched a review into Meta’s attempts to enter the Chinese market. According to
PVH soared 18% after the parent company of Calvin Klein and Tommy Hilfiger reported stronger-than-expected fourth-quarter earnings and revenue. PVH posted adjusted earnings of $3.27
Johnson & Johnson shares tumbled after a US bankruptcy judge rejected the company’s proposed $10bn settlement related to lawsuits alleging its talc products caused ovarian
At Cratos Asset Management, we aim to offer clients a wide range of financial products and services in order to enable them to achieve their personal financial aspirations.
© 2025 All rights reserved.
Subscribe to fund newsletter